Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 14OTHER 10NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 11Thoracic 5Gynecologic 3Dermatologic 3CNS 3Breast 3Tumor-Agnostic 2Endocrine 2Other solid neoplasm 1NET 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Thyroid Neoplasms 31Thyroid Cancer, Papillary 26Pheochromocytoma 23Adenocarcinoma, Follicular 23Adrenocortical Carcinoma 21Neuroendocrine Tumors 20Carcinoma, Medullary 17Somatostatinoma 14Insulinoma 14Thyroid Carcinoma, Anaplastic 13Pituitary Neoplasms 13Paraganglioma 13Carcinoma, Neuroendocrine 12Glucagonoma 11Carcinoma, Renal Cell 11Parathyroid Neoplasms 10Pancreatic Neoplasms 10Gastrinoma 10Carcinoma, Non-Small-Cell Lung 10Carcinoma, Hepatocellular 10Head and Neck Neoplasms 9Colonic Neoplasms 9Carcinoma, Islet Cell 9Breast Neoplasms 9Small Cell Lung Carcinoma 8Sarcoma 8Neoplasms 8Rectal Neoplasms 7Multiple Endocrine Neoplasia Type 1 7Adrenal Gland Neoplasms 7

Interventions

belinostat 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Carcinoma × Endocrine × Clear all
NCT00923026 2026-06-03

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
1,150 enrolled
DermatologicEndocrineNET

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT00926640 2018-10-19

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
28 enrolled
EndocrineThoracic

Carcinoma, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡